Survival predictors in second-line chemotherapy for metastatic gastric cancer

被引：0
|
作者：
Bohanes, P. O. [1 ]
Courvoisier, D. [1 ]
Perneger, T. [1 ]
Morel, P. [1 ]
Huber, O. [1 ]
Roth, A. D. [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15575
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer
    Bohanes, Pierre
    Courvoisier, Delphine S.
    Perneger, Thomas V.
    Morel, Philippe
    Huber, Olivier
    Roth, Arnaud D.
    SWISS MEDICAL WEEKLY, 2011, 141
  • [2] Not only chemotherapy in the second-line treatment of metastatic gastric cancer
    Vasile, E.
    Caparello, C.
    Caponi, S.
    Ginocchi, L.
    Vivaldi, C.
    Musettini, G.
    Lucchesi, M.
    Lencioni, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 544 - 545
  • [3] SECOND-LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER: A RETROSPECTIVE ANALYSIS
    Alexandre, Maria Teresa
    Luis, Ana Carla
    Clara, Ana
    Fonseca, Vasco
    Freire, Joao
    Moreira, Antonio
    ANNALS OF ONCOLOGY, 2012, 23 : 49 - 49
  • [4] Metastatic gastric cancer: does second-line chemotherapy make sense?
    Breithaupt, K.
    Thuss-Patience, P. C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (38) : 1872 - 1876
  • [5] A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy
    Kanagavel, D.
    Pokataev, I. A.
    Fedyanin, M. Y.
    Tryakin, A. A.
    Bazin, I. S.
    Narimanov, M. N.
    Yakovleva, E. S.
    Garin, A. M.
    Tjulandin, S. A.
    ANNALS OF ONCOLOGY, 2010, 21 (09) : 1779 - 1785
  • [6] A PROGNOSTIC MODEL IN PATIENTS TREATED FOR METASTATIC GASTRIC CANCER WITH SECOND-LINE CHEMOTHERAPY
    Kanagavel, D.
    Bazin, I
    Narimanov, M.
    Garin, A.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 83 - 83
  • [7] Continuing bevacizumab with second-line chemotherapy for metastatic colorectal cancer prolongs survival
    不详
    COLORECTAL CANCER, 2012, 1 (04) : 281 - 282
  • [8] LDH levels as predictors of efficacy in second-line treatment for metastatic gastric cancer: The LINE study
    Michelotti, A.
    Ongaro, E.
    Gerratana, L.
    De Scordilli, M.
    Di Nardo, P.
    Foltran, L.
    Guardascione, M.
    Basile, D.
    Cortiula, F.
    Miolo, G.
    Parnofiello, A.
    Bertoli, E.
    Lisanti, C.
    Buriolla, S.
    Buonadonna, A.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S176 - S177
  • [9] Prognostic factors in metastatic gastric cancer patients (pts) treated with second-line chemotherapy
    Catalano, V.
    Graziano, F.
    Santini, D.
    Baldelli, A. M.
    Giordani, P.
    Vincenzi, B.
    Rossi, D.
    Alessandroni, P.
    Tonini, G.
    Catalano, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Second-Line Irinotecan after Cisplatin, Fluoropyrimidin and Docetaxel for Chemotherapy of Metastatic Gastric Cancer
    Kucukzeybek, Yuksel
    Dirican, Ahmet
    Erten, Cigdem
    Somali, Isil
    Can, Alper
    Demir, Lutfiye
    Bayoglu, Ibrahim Vedat
    Akyol, Murat
    Medeni, Murat
    Tarhan, Mustafa Oktay
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (06) : 2771 - 2774
12345